Medtronic said Monday it received 510 (k) clearance from the Food and Drug Administration for an app to connect its smart ...
The FDA has granted 510(k) clearance to Medtronic for its MiniMed “Go Smart” multiple daily injection system — the first ...
Once-weekly semaglutide 1 mg was tied to a reduction in total daily insulin dose among adults with type 1 diabetes, ...
The FDA has cleared the first app that integrates glucose data with multiple daily injection (MDI) insulin dosing for people with diabetes.
The FDA has cleared a mobile application that will connect with a next-generation multiple daily injection automated insulin ...
USA: In a post hoc analysis of the ADJUST-T1D trial, adults with type 1 diabetes receiving once-weekly semaglutide 1 mg showed a significant reduction in total daily insulin dose by 4 weeks, ...
ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve ...
Weekly insulin dose aces phase 3 trials for easier diabetes management By Michael Irving October 30, 2023 A once-a-week insulin shot has shown promise in a phase three clinical trial Depositphotos ...
If you have certain types of diabetes, your doctor might suggest Fiasp as a treatment option for you. It’s a prescription drug used to control blood sugar levels in: adults and children with type 1 ...
Lyumjev (insulin lispro-aabc) is prescribed to manage blood sugar levels in certain people with type 1 or 2 diabetes. The drug comes as a liquid solution for injection as directed by your doctor. The ...
Afrezza (insulin human) is a brand-name inhaled insulin prescribed to manage blood sugar in adults with diabetes. It comes as a powder that you typically take at mealtimes. The dosage can vary based ...
For information about Fiasp dosing, including the drug’s strength and how to take the medication, keep reading. For a comprehensive look at Fiasp, see this article. This article describes typical ...